Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.sciencedirect.com › science › articleIvermectin for treatment of COVID-19: A systematic review and...

   www.sciencedirect.com › science › article

   30 mar 2024 · The effect of ivermectin (IVM) in treating coronavirus disease 2019 (COVID-19) is still controversial, yet the drug has been widely used in the world. The aim of this review was to systematically evaluate the clinical outcomes of IVM in patients with COVID-19.

   • Efficacy and safety of ivermectin for treatment of non-hospitalized ...

     Five databases were searched until October 17, 2023, for...

2. www.nejm.org › doi › fullEffect of Early Treatment with Ivermectin among Patients with...

   www.nejm.org › doi › full

   30 mar 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the...

3. pmc.ncbi.nlm.nih.gov › articles › PMC9308124Systematic review and meta-analysis of ivermectin for treatment...

   pmc.ncbi.nlm.nih.gov › articles › PMC9308124

   Ravikirti, Roy R, Pattadar C, Raj R, Agarwal N, Biswas B, Manjhi PK, et al. Evaluation of ivermectin as a potential treatment for mild to moderate COVID-19: a double-blind randomized placebo controlled trial in Eastern India.

4. www.sciencedirect.com › science › articleEfficacy and safety of ivermectin for treatment of...

   www.sciencedirect.com › science › article

   1 sie 2024 · Five databases were searched until October 17, 2023, for randomized controlled trials (RCTs) in adult patients with COVID-19 treated with ivermectin against standard of care (SoC), placebo, or active drug. Primary outcomes were hospitalization, all-cause mortality, and adverse events (AEs).

5. pubmed.ncbi.nlm.nih.gov › 34265236Evaluation of Ivermectin as a Potential Treatment for Mild to...

   pubmed.ncbi.nlm.nih.gov › 34265236

   Methods: A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern India. Enrolment was done between 1st August and 31st October 2020.

6. pmc.ncbi.nlm.nih.gov › articles › PMC10071928Association between ivermectin treatment and mortality in...

   pmc.ncbi.nlm.nih.gov › articles › PMC10071928

   This study was designed with the primary objective of estimating the association of ivermectin treatment with mortality in patients admitted with COVID-19. A secondary objective was the estimation of the extent of reduction, if any, in duration of hospital stay in survivors who received ivermectin.

7. pubmed.ncbi.nlm.nih.gov › 33592050Role of ivermectin in the prevention of SARS-CoV-2 infection...

   pubmed.ncbi.nlm.nih.gov › 33592050

   16 lut 2021 · The study was aimed to explore the association between ivermectin prophylaxis and the development of SARS-CoV-2 infection among healthcare workers. Methods: A hospital-based matched case-control study was conducted among healthcare workers of AIIMS Bhubaneswar, India, from September to October 2020.